newsfilter
← Latest News
Business Wire·

Enveric Biosciences to Participate in the UBS 3rd Virtual CNS Day

Enveric Biosciences (NASDAQ:ENVB) ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced